Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Oncología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
RENIS
Acceso a Medicamentos Oncologicos en Argentina. 2006-2012
OBSERVATIONAL
ID: IS000012
Completado
RENIS
Tratamiento concurrente (RT + QT) del carcinoma epidermoide o adenocarcinoma de cuello uterino con CIGB-300 de aplicación local
INTERVENTIONAL
ID: IS000008
Completado
Fase 2
ClinicalTrials.gov
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia (Part 1: Open-label, Part 2: Randomized, Double-blind, Part 3: Extension)
INTERVENTIONAL
Inicio: 1 de sept de 2011
ID: NCT01440374
Activo, no recluta
Fase 3
ClinicalTrials.gov
Phase 3, Randomized Study to Evaluate the Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy Compared With Standard of Care Therapy as First-line Intervention in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (LEAP-015)
INTERVENTIONAL
Inicio: 30 de dic de 2020
ID: NCT04662710
Completado
Fase 3
ClinicalTrials.gov
A Phase III Study of Novel Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated With an Anthracycline and a Taxane
INTERVENTIONAL
Inicio: 1 de nov de 2003
ID: NCT00082433
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Golcadomide Plus R-CHOP Chemotherapy vs Placebo Plus R-CHOP Chemotherapy in Participants With Previously Untreated High-risk Large B-cell Lymphoma (GOLSEEK-1)
INTERVENTIONAL
Inicio: 19 de jun de 2024
ID: NCT06356129
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double Blind Phase III Study To Evaluate Adjuvant cG250 Treatment Versus Placebo In Patients With Clear Cell RCC And High Risk of Recurrence (ARISER)
INTERVENTIONAL
Inicio: 1 de jul de 2004
ID: NCT00087022
Completado
Fase 3
ClinicalTrials.gov
Phase 3 Randomized Comparison of Concurrent Gemcitabine, Cisplatin, and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Cancer of the Cervix Stages IIB to IVA
INTERVENTIONAL
Inicio: 1 de may de 2002
ID: NCT00191100
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase I/II, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Anti-tumor Efficacy of DZD9008 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With EGFR or HER2 Mutation
INTERVENTIONAL
Inicio: 9 de jul de 2019
ID: NCT03974022
Completado
Fase 2
ClinicalTrials.gov
SIOP Study of Combined Modality Treatment in Childhood Ependymoma
INTERVENTIONAL
Inicio: 1 de ene de 1999
ID: NCT00004224
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
INTERVENTIONAL
Inicio: 1 de oct de 2003
ID: NCT00101998
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors
INTERVENTIONAL
Inicio: 1 de ene de 2013
ID: NCT01721044
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Double-blind, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK Inhibitor Therapy and Who Require Red Blood Cell Transfusions
INTERVENTIONAL
Inicio: 25 de feb de 2021
ID: NCT04717414
Completado
Fase 3
ClinicalTrials.gov
An Open Label, Randomized Phase 3 Clinical Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN)
INTERVENTIONAL
Inicio: 29 de may de 2014
ID: NCT02105636
Activo, no recluta
ClinicalTrials.gov
A Non-Interventional, Multicenter, Multiple Cohort Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
OBSERVATIONAL
Inicio: 7 de feb de 2019
ID: NCT03782207
Completado
ClinicalTrials.gov
Evaluation of the AFP Model in Predicting Recurrence of Hepatocellular Carcinoma After Liver Transplantation in Patients Without Microvascular Invasion.
OBSERVATIONAL
Inicio: 11 de nov de 2017
ID: NCT03775863
Activo, no recluta
ClinicalTrials.gov
Surveillance AFter Extremity Tumor surgerY (SAFETY) International Randomized Controlled Trial
INTERVENTIONAL
Inicio: 19 de nov de 2019
ID: NCT03944798
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind Study of Tivantinib (ARQ 197) in Subjects With MET Diagnostic-High Inoperable Hepatocellular Carcinoma Treated With One Prior Systemic Therapy
INTERVENTIONAL
Inicio: 27 de dic de 2012
ID: NCT01755767
Completado
Fase 3
ClinicalTrials.gov
Phase III Randomized Trial of BIBW 2992 Plus Weekly Paclitaxel Versus Investigator's Choice of Chemotherapy Following BIBW 2992 Monotherapy in Non-small Cell Lung Cancer Patients Failing Previous Erlotinib or Gefitinib Treatment (LUX Lung 5)
INTERVENTIONAL
Inicio: 1 de feb de 2010
ID: NCT01085136
Desconocido
ClinicalTrials.gov
Real World Evidence of Brentuximab Vedotin Consolidation in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma Who Receive Salvage Chemotherapy and Autologous Stem Cell Transplant
OBSERVATIONAL
Inicio: 1 de jun de 2021
ID: NCT04776265
Anterior
1
...
16
17
18
...
434
Siguiente
Filtros